Selective Bladder Denervation via Radiofrequency Ablation Versus Intravesical Onabotulinum Toxin A for Refractory Overactive Bladder: The Short‐Term Results of A Preliminary Randomized Controlled Trial

Documenti analoghi

• Impact of Lower Urinary Tract Symptoms on Daily Life in Individuals With Co‐Existence Overactive and Underactive Bladder, Overactive Bladder, and Underactive Bladder
  di: Noritoshi Sekido, et al.
  Pubblicazione: (2025)
• Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome
  di: Wan‐Ru Yu, et al.
  Pubblicazione: (2026)
• Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”
  Pubblicazione: (2026)
• Overactive Bladder is Positively Associated With the Prevalence and Mortality of Cancer Among US Adults
  di: Jianing Liu, et al.
  Pubblicazione: (2025)
• Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey
  di: Shoko Yoshimura, et al.
  Pubblicazione: (2024)